Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.908 SEK | -0.22% | +1.57% | -26.18% |
06-28 | Nanexa AB Announces Chief Financial Officer Changes | CI |
06-11 | Nanexa AB Announces That First Patient Dosed in Nanexa's Phase I Trial of NEX-22 in Type 2 Diabetes | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-26.18% | 11.62M | |
-0.04% | 217M | |
-67.28% | 74.59M |
- Stock Market
- Equities
- NANEXA Stock
- News Nanexa AB
- Nanexa AB Elects New Board Members